Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MTN -2.4%
Other news:
- ARTL -20.5% (commences underwritten public offering of its common stock and/or pre-funded warrants; all shares of common stock and/or pre-funded warrants in the offering are to be offered by the Company)
- FLY -11.2% (reports that the booster stage for its Alpha rocket was destroyed during testing mishap, according to Reuters)
- ATAI -9.9% (mixed securities shelf offering; also stock offering by selling shareholders)
- UUUU -7.6% (convertible notes offering)
- BTBT -7.2% (prices $135 mln of 4.00% convertible senior notes due 2030)
- TLRY -3.8% (announces expansion of premium craft cannabis production at its advanced EU-GMP facility in Germany; Tilray Medical enhances Tilray craft cannabis portfolio with new patient-centered offerings)
- OCUL -2.4% (to highlight exceptional AXPAXLI progress across SOL program and detail registrational trial plans to pursue a diabetic retinopathy label with a novel primary endpoint)
- NVO -2.3% (resubmits Awiqli BLA to the FDA)
- ETSY -1.8% (to transfer listing to NYSE)
- INTC -1.8% (completed the issuance and sale of 86,956,522 shares of common stock to SoftBank Group Corp. (SFTBY) at $23/share for $2.0 billion)
- FFAI -1.6% (closes strategic investment in Qualigen Therapeutics)
- AA -1.3% (to close Kwinana Refinery; updates Q3 outlook)
- SAND -1.1% (Investment Canada approval received, Sandstorm reminds shareholders of voting deadline for upcoming special meeting)